What type of drug is Steglatro?
Medically reviewed by Drugs.com. Last updated on Feb 16, 2023.
Steglatro (ertugliflozin) is an oral sodium-glucose cotransporter 2 (SGLT2) inhibitor.
This drug is used with diet and exercise to improve blood sugar control in adults with type 2 diabetes.
The SGLT2 inhibitors block the kidney from reabsorbing sugar (glucose), which is then eliminated in the urine and lowers blood sugar.
Related medical questions
- What is the safest diabetes medication?
- What foods should I eat or avoid for hypoglycemia?
- Can you have hypoglycemia without diabetes?
- What is the connection between the endocrine system and osteoporosis?
- Which type of insulin has the longest duration of action?
- What are 4 key Ozempic side effects to watch out for?
- Mounjaro vs Ozempic: How do they compare?
- How long does it take for Ozempic to work?
- How many doses are in an Ozempic pen?
- Is Mounjaro covered by insurance or Medicare?
- What happens when you stop taking Ozempic?
- Steglatro Information for Consumers
- Steglatro prescribing info & package insert (for Health Professionals)
- Side Effects of Steglatro (detailed)